Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study
- PMID: 27382092
- DOI: 10.1200/JCO.2015.64.6729
Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study
Abstract
Purpose: According to the lung cancer staging project, T1a (≤ 2 cm) non-small-cell lung cancer (NSCLC) should be additionally classified into ≤ 1 cm and > 1 to 2 cm groups. This study aimed to investigate the surgical procedure for NSCLC ≤ 1 cm and > 1 to 2 cm.
Methods: We identified 15,760 patients with T1aN0M0 NSCLC after surgery from the Surveillance, Epidemiology, and End Results database. Overall survival (OS) and lung cancer-specific survival (LCSS) were compared among patients after lobectomy, segmentectomy, or wedge resection. The proportional hazards model was applied to evaluate multiple prognostic factors.
Results: OS and LCSS favored lobectomy compared with segmentectomy or wedge resection in patients with NSCLC ≤ 1 cm and > 1 to 2 cm. Multivariable analysis showed that segmentectomy and wedge resection were independently associated with poorer OS and LCSS than lobectomy for NSCLC ≤ 1 cm and > 1 to 2 cm. With sublobar resection, lower OS and LCSS emerged for NSCLC > 1 to 2 cm after wedge resection, whereas similar survivals were observed for NSCLC ≤ 1 cm. Multivariable analyses showed that wedge resection is an independent risk factor of survival for NSCLC > 1 to 2 cm but not for NSCLC ≤ 1 cm.
Conclusion: Lobectomy showed better survival than sublobar resection for patients with NSCLC ≤ 1 cm and > 1 to 2 cm. For patients in whom lobectomy is unsuitable, segmentectomy should be recommended for NSCLC > 1 to 2 cm, whereas surgeons could rely on surgical skills and the patient profile to decide between segmentectomy and wedge resection for NSCLC ≤ 1 cm.
© 2016 by American Society of Clinical Oncology.
Comment in
-
Reply to B. De Bari et al and J. Widder et al.J Clin Oncol. 2017 Feb 10;35(5):574-575. doi: 10.1200/JCO.2016.70.6960. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893324 No abstract available.
-
Can Segmentectomy Still Be Proposed As an Alternative to Lobectomy in 2016?J Clin Oncol. 2017 Feb 10;35(5):573-574. doi: 10.1200/JCO.2016.69.9140. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893334 No abstract available.
-
Lobectomy or Sublobectomy for Small Non-Small-Cell Lung Cancer: The Question Remains.J Clin Oncol. 2017 Feb 10;35(5):572-573. doi: 10.1200/JCO.2016.70.0872. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893336 No abstract available.
-
Limited resection versus lobectomy in early-stage non-small cell lung cancer.J Thorac Dis. 2016 Nov;8(11):E1511-E1513. doi: 10.21037/jtd.2016.11.71. J Thorac Dis. 2016. PMID: 28066646 Free PMC article. No abstract available.
-
Treatment of non-small cell lung cancer ≤2 cm in size: less may not be more.Ann Transl Med. 2016 Dec;4(24):503. doi: 10.21037/atm.2016.12.59. Ann Transl Med. 2016. PMID: 28149865 Free PMC article. No abstract available.
-
Current trends in lung resection for T1a non-small cell lung cancer: is lobectomy still the answer?J Thorac Dis. 2017 Feb;9(2):E164-E165. doi: 10.21037/jtd.2017.02.26. J Thorac Dis. 2017. PMID: 28275506 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
